Chronos Therapeutics Ltd.

Flipkart to enter healthcare space via SastaSundar acquisition One of India's leading e-commerce platforms, Flipkart, has signed definitive agreements to buy a majority stake at online pharmacy startup SastaSundar. The Kolkota-based startup works with over 490 pharmacies to deliver healthcare products across the country. It also uses AI and data analytics to offer counselling services via its platform. The Walmart-backed e-commerce site plans to name its newly acquired healthcare entity Flipkart Health+ upon transaction's close, a news report said. "With growing awareness and focus on health heightened by the pandemic, there is a large opportunity and demand for affordable healthcare and ancillary offerings," noted Ravi Iyer, SVP and head of corporate development at Flipkart. "The synergies between the Flipkart Group and SatsaSundar.com, combined with our commitment to prioritise our customer’s needs, will help us grow and transform online healthcare in India," he added. One of SastaSundar's founders, BL Mittal, also commented: "Through this partnership with Flipkart, we see an opportunity to further grow and reach a larger consumer base, using complementary technologies and logistics infrastructure". Australian life sciences firm Trajan buys German lab automation maker ASX-listed life sciences company Trajan has acquired the private business and properties of Axel Semrau, developer of laboratory automation software in Germany. It bought Axel Semrau, manufacturer of ​​chromatography and mass spectrometry systems, for 14.75 million euros ($16.5 million) and its real-estate business Semrau Immobilien for 2.25 million euros ($2.5 million). Both companies have already established a partnership for several years, according to Trajan CEO and Managing Director Stephen Tomisich. Trajan's automated workflows, which is built on Axel Semrau's CHRONOS intelligent sequencing software platform, is proof of this existing collaboration. "We intend to further invest in CHRONOS in line with Trajan's goal to simplify and automate complex analytical workflows," Tomisich said in a press release. Commenting on the acquisition, Andreas Bruchmann, managing director at Axel Semrau, said: "We have known Trajan for some time and find that our goals and values are aligned. We also see the intention of ongoing investment to drive growth in our business and capabilities". HP Malaysia unveils its latest tech support products for healthcare, other businesses HP Malaysia has introduced its latest Engage products that assist businesses in various industries, including healthcare, to optimise their operations. HP Engage Go 10” is a highly durable and compact tablet that helps reduce clerical errors and ease data admission or registration process. The portable device can be installed at a patient's bedside or in an ambulance and can be used for managing patient data or as a pharmacy point of sale system. Meanwhile, the HP Engage Flex Mini is a platform that can be adapted for any industrial application from medical lasers to surgical robots. HP mentioned that it has been used as an OEM controller for medical devices, clinical instrumentation, patient self-check-in kiosks, and automated pharmacy systems, among others. "Combining sleek designs with options as a fixed integrated device or a mobile device, the Engage portfolio offers expanded capabilities needed to run a wide range of operations for [various] businesses," said HP Malaysia Managing Director Alex Tan.

Summary Chronos Therapeutics Ltd Chronos is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its pipeline products comprise RDC5 neurodegenerative and RDC5 obesity products. Chronos develops drugs for treatment of major human diseases of ageing, such as Alzheimer's disease, Huntington's disease, diabetes and osteoporosis. The company provides Chronoscreen, a screening platform to assess repositioned and novel drug leads based on their activity and regulation of cellular lifespan. It also provides commercial partnerships and academic collaborations with other research centers. Chronos is headquartered in Oxford, the UK. Chronos Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.